This bill matters because it fundamentally changes who bears the financial risk when someone claims to be injured by a COVID-19 vaccine. If this bill becomes law, vaccine manufacturers could be held directly responsible in civil courts for alleged harms caused by their vaccines, potentially leading to significant legal and financial consequences for these companies.

Currently, federal law provides certain protections for vaccine manufacturers, often channeling compensation claims through government programs. This bill would shift that dynamic, giving individuals more direct avenues for legal recourse against manufacturers. Voters should care because it addresses questions of corporate accountability, individual rights to seek legal remedy, and could influence how pharmaceutical companies approach vaccine development and distribution in future public health crises by altering their liability exposure.